REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/18/2026
Back to search
Official data from USPTO
LINNEA 315CSE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LINNEA 315CSE
ST13
US500000088589105Class
1, 5
Filing
88589105
Registration
6351234
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
05/19/2026
Trademark type
Word
Nice classes
1, 5
Filing date
08/22/2019
Registration date
05/18/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/18/2021
Last transaction
05/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Riazzino, CH
Examiner
JOHNSON, AISHA CLARKE
Current location
Historical data usage
Holders and representatives
Holders
LINNEA SA
Representatives
Perla M. Kuhn FOX ROTHSCHILD LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical additives for use in the manufacture of pharmaceuticals; botanical extractsactive substances and active chemical ingredients for use in the manufacture of pharmaceuticals; botanical extractsactive substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseasesneuropathic paincancer painautoimmune diseasesanorexiaAIDSpsychiatric disordersneurovegetative disordersmetabolic disorderscardiovascular disordersrespiratory diseasesgastrointestinal disordersdisorders of the central nervous systemdisorders of the immune system; botanical extractsactive substances and active chemical ingredients for use in the manufacture of veterinary preparations; plant extractsactive compounds and active chemical ingredients for use in the manufacture of pharmaceuticals; plant extractsactive substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseasesneuropathic paincancer painautoimmune diseasesanorexiaAIDSpsychiatric disordersneurovegetative disordersmetabolic disorderscardiovascular disordersrespiratory diseasesgastrointestinal disordersdisorders of the central nervous systemdisorders of the immune system; chemicals for use in the manufacture of cosmetics and food; botanical extracts for use in the manufacture of cosmetics and food; botanical extracts for use in the manufacture of cosmetics and dietary supplements; food preserving chemicals; plant extractsactive substances and active chemical ingredients for use in the manufacture of cosmetics and dietary supplements
Class 5
Pharmaceuticals derived from botanical and plant extracts; pharmaceuticals derived from botanical and plant extracts for veterinary purposes; pharmaceuticals derived from botanical and plant extracts for use in the treatment of skin diseasesneuropathic paincancer painautoimmune diseasesanorexiaAIDSpsychiatric disordersneurovegetative disordersmetabolic disorderscardiovascular disordersrespiratory diseasesgastrointestinal disordersdisorders of the central nervous systemdisorders of the immune system; medicines for veterinary purposes; dietary supplements based on botanical and plant extracts; dietary supplements based on botanical and plant extracts for pharmaceutical and veterinary purposes; dietary supplements based on botanical and plant extracts in the form of pharmaceuticals for treating skin diseasesneuropathic paincancer painautoimmune diseasesanorexiaAIDSpsychiatric disordersneurovegetative disordersmetabolic disorderscardiovascular disordersrespiratory diseasesgastrointestinal disordersdisorders of the central nervous systemdisorders of the immune system; plant extractsactive substances and active chemical ingredients for veterinary use; plant extractsactive substances and active chemical ingredients for use in the pharmaceutical industry; plant extractsactive substances and active chemical ingredients for use in the cosmetics industry; chemical preparations for pharmaceutical or medical purposesfor use in the treatment of skin diseasesneuropathic paincancer painautoimmune diseasesanorexiaAIDSpsychiatric disordersneurovegetative disordersmetabolic disorderscardiovascular disordersrespiratory diseasesgastrointestinal disordersdisorders of the central nervous systemdisorders of the immune system
Publications
History of USPTO decisions and trademark events.
26 publications found
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
04/29/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/26/2024
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
09/23/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/12/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/18/2021
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
04/09/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/09/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
01/20/2021
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
01/20/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/15/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/21/2020
PUBO
PUBLISHED FOR OPPOSITION
07/21/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/16/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2020
ALIE
ASSIGNED TO LIE
06/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/03/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/04/2019
GNRT
NON-FINAL ACTION E-MAILED
12/04/2019
CNRT
NON-FINAL ACTION WRITTEN
12/04/2019
DOCK
ASSIGNED TO EXAMINER
11/21/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/09/2019
NWAP
NEW APPLICATION ENTERED
08/26/2019
Continuous trademark protection
Get notified about every new filing that threatens LINNEA 315CSE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.